Table 3.
| Group | Compound | IC50 (μM) ± SD | Inhibition of colchicine binding (%) ± SD |
|---|---|---|---|
| 2 | NA | - | |
| I | 3 | 2.3 ± 0.08 | 43 ± 10 |
| 6 | 2.7 ± 0.1 | 50 ± 0.4 | |
| 8 | 2.7 ± 0.3 | 31 ± 3 | |
| 11 | Not obtainablec | 29 ± 0.4 | |
| 35 | 2.5 ± 0.2 | 37 ± 5 | |
| II | 15 | 6.5 ± 0.7 | 33 ± 2 |
| 21 | 2.0 ± 0.1 | 78 ± 5 | |
| 22 | 3.4 ± 0.3 | 38 ± 4 | |
| 26 | 3.4 ± 0.2 | 52 ± 0.6 | |
| 36 | 3.7 ± 0.09 | 36 ± 4 | |
| 37 | 2.4 ± 0.007 | 69 ± 3 | |
| CA-4 | 1.1 ± 0.1 | 99 ± 0.7 | |
The tubulin assembly assay measured the extent of assembly of 10 μM tubulin after 20 min at 30 °C.
Tubulin: 1 sμM, [3H]Colchicine: 5 μM, Inhibitor: 5 μM. Incubation was for 10 min at 37 °C.
Partial inhibition observed and was maximal with 4 μM compound. Higher compound concentrations resulted in the same amount of inhibition observed with 4 μM, suggesting poor solubility of 11 in the reaction mixture.